Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-06-26

Clinical Trial Update: The Safety and Immunogenicity Research of Live Attenuated Varicella Vaccine After the 2 Doses Vaccination [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update evaluates the safety and immunogenicity of a live attenuated varicella vaccine after two doses. The study is conducted by the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Varicella vaccine, live attenuated (varicella vaccine, live attenuated)

Snippet

Sponsor: Beijing Center for Disease Control and Prevention | Conditions: Varicella | Phase 4 | Status: UNKNOWN